Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
SJ Tabrizi, C Estevez-Fraga… - The Lancet …, 2022 - thelancet.com
Huntington's disease is the most frequent autosomal dominant neurodegenerative disorder;
however, no disease-modifying interventions are available for patients with this disease. The …
however, no disease-modifying interventions are available for patients with this disease. The …
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
AN Brandebura, A Paumier, TS Onur… - Nature Reviews …, 2023 - nature.com
There is increasing appreciation that non-neuronal cells contribute to the initiation,
progression and pathology of diverse neurodegenerative disorders. This Review focuses on …
progression and pathology of diverse neurodegenerative disorders. This Review focuses on …
Advancing cell therapy for neurodegenerative diseases
S Temple - Cell stem cell, 2023 - cell.com
Cell-based therapies are being developed for various neurodegenerative diseases that
affect the central nervous system (CNS). Concomitantly, the roles of individual cell types in …
affect the central nervous system (CNS). Concomitantly, the roles of individual cell types in …
Protein misfolding in neurodegenerative diseases: implications and strategies
P Sweeney, H Park, M Baumann, J Dunlop… - Translational …, 2017 - Springer
A hallmark of neurodegenerative proteinopathies is the formation of misfolded protein
aggregates that cause cellular toxicity and contribute to cellular proteostatic collapse …
aggregates that cause cellular toxicity and contribute to cellular proteostatic collapse …
Single-nucleus RNA-seq identifies Huntington disease astrocyte states
O Al-Dalahmah, AA Sosunov, A Shaik, K Ofori… - Acta neuropathologica …, 2020 - Springer
Huntington Disease (HD) is an inherited movement disorder caused by expanded CAG
repeats in the Huntingtin gene. We have used single nucleus RNASeq (snRNASeq) to …
repeats in the Huntingtin gene. We have used single nucleus RNASeq (snRNASeq) to …
Polyglutamine repeats in neurodegenerative diseases
AP Lieberman, VG Shakkottai… - Annual Review of …, 2019 - annualreviews.org
Among the age-dependent protein aggregation disorders, nine neurodegenerative diseases
are caused by expansions of CAG repeats encoding polyglutamine (polyQ) tracts. We …
are caused by expansions of CAG repeats encoding polyglutamine (polyQ) tracts. We …
SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions
Astrocytes have in recent years become the focus of intense experimental interest, yet
markers for their definitive identification remain both scarce and imperfect. Astrocytes may …
markers for their definitive identification remain both scarce and imperfect. Astrocytes may …
Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain
R Vieira, JN Mariani, NPT Huynh… - Nature …, 2024 - nature.com
Competition among adult brain cells has not been extensively researched. To investigate
whether healthy glia can outcompete diseased human glia in the adult forebrain, we …
whether healthy glia can outcompete diseased human glia in the adult forebrain, we …
Astrocyte molecular signatures in Huntington's disease
Astrocytes are implicated in neurodegenerative disorders and may contribute to striatal
neuron loss or dysfunction in Huntington's disease (HD). Here, we assessed striatal …
neuron loss or dysfunction in Huntington's disease (HD). Here, we assessed striatal …
Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes
Astrocytes play important roles in neurological disorders such as stroke, injury, and
neurodegeneration. Most knowledge on astrocyte biology is based on studies of mouse …
neurodegeneration. Most knowledge on astrocyte biology is based on studies of mouse …